These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32615531)

  • 1. Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
    Dolbec K; Chalkley J; Sudhakar P
    Mult Scler Relat Disord; 2020 Sep; 44():102342. PubMed ID: 32615531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease.
    Lotan I; Hellmann MA; Benninger F; Stiebel-Kalish H; Steiner I
    J Neuroimmunol; 2018 Nov; 324():115-118. PubMed ID: 30267996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
    Salama S; Khan M; Levy M; Izbudak I
    Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
    Narayan R; Simpson A; Fritsche K; Salama S; Pardo S; Mealy M; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Oct; 25():66-72. PubMed ID: 30048919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS.
    Etemadifar M; Salari M; Etemadifar MR; Sabeti F; Fateh ST; Aminzade Z
    Mult Scler Relat Disord; 2022 Apr; 60():103664. PubMed ID: 35219242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
    Caron-Cantin M; Cestari DM; Fortin E
    Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
    Ojha PT; Aglave VB; Soni G; Jagiasi KA; Singh RK; Singh RK; Nagendra S
    Neurol India; 2020; 68(5):1106-1114. PubMed ID: 33109860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
    Tajfirouz DA; Bhatti MT; Chen JJ
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
    Rosenthal JF; Hoffman BM; Tyor WR
    J Investig Med; 2020 Feb; 68(2):321-330. PubMed ID: 31582425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.
    Juryńczyk M; Jacob A; Fujihara K; Palace J
    Pract Neurol; 2019 Jun; 19(3):187-195. PubMed ID: 30530724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
    Wildemann B; Horstmann S; Korporal-Kuhnke M; Viehöver A; Jarius S
    Klin Monbl Augenheilkd; 2020 Nov; 237(11):1290-1305. PubMed ID: 33202462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
    O'Connell K; Hamilton-Shield A; Woodhall M; Messina S; Mariano R; Waters P; Ramdas S; Leite MI; Palace J
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1126-1128. PubMed ID: 32576617
    [No Abstract]   [Full Text] [Related]  

  • 19. [Typical and atypical optic neuritis].
    Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
    Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Multiple Sclerosis with Antibody to MOG.
    Dave D; Khan F; Rohatgi S; Nirhale S; Rao P; Naphade P
    Neurol India; 2020; 68(5):1235-1237. PubMed ID: 33109887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.